
What We’re Reading: FDA Approves RSV Vaccine; Medicare to Cover Alzheimer Drugs; More States Extend Postpartum Coverage
The FDA approved Pfizer’s respiratory syncytial virus (RSV) vaccine Wednesday; Medicare announced plans to largely cover a new class of expensive Alzheimer drugs; more states are extending postpartum coverage under Medicaid.
FDA Approves Pfizer RSV Vacccine
The FDA approved Pfizer’s respiratory syncytial virus (RSV) vaccine (Abrysvo) for adults age 60 and older on Wednesday, the second approval granted for a shot offering protection from the virus,
Medicare to Expand Alzheimer Drug Coverage
Medicare officials announced plans Thursday to largely cover a new class of Alzheimer drugs after patient advocates and drugmakers called for access to these medications, which are the first shown to slow cognitive decline from the illness,
More States Extend Postpartum Coverage
At least 8 states in 2023 have decided to pursue federal approval to extend postpartum Medicaid coverage, leaving just a few that have decided not to guarantee at least a year of health care for women during the important period after pregnancy,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.